DiaSorin stock reacts as Technoprobe set to replace it in FTSE MIB

DiaSorin stock is in focus as index provider FTSE Russell prepares to add Technoprobe to the FTSE MIB later in September, prompting portfolio shifts while the diagnostics group continues to trade steadily on Borsa Italiana.

DiaSorin stock (ISIN IT0003497168) is trading in a tight range on Borsa Italiana around 76 euros as of September 3, 2026, while investors digest the upcoming change in Italy's FTSE MIB index that will see Technoprobe take its place later in the month.

FTSE MIB reshuffle puts DiaSorin in the spotlight

According to market data compiled by Borsa Italiana on September 3, 2026, DiaSorin shares were quoted at approximately 76.22 euros, with a price at 75.84 euros earlier in the session and a daily percentage change of about plus 0.50 percent, indicating a modest gain on the day.

A separate overview of Italian stocks to watch on September 3, 2026 notes DiaSorin at around 76.54 euros on the Milan exchange, reflecting a similar price level and a small positive intraday move in the order of 0.21 percent, which underlines the stock's relatively stable trading behavior despite the index news.

Technoprobe set to replace DiaSorin in FTSE MIB

A recent Italian market report explains that Technoprobe is scheduled to replace DiaSorin in the FTSE MIB index on September 21, 2026, concentrating buy and sell orders in a narrow time window as passive funds tracking the benchmark adjust their holdings to reflect the new composition.

Another piece from the Italian financial press highlights that Technoprobe has already been trading actively around 27.08 euros, up about 1.35 percent in the latest quote, while DiaSorin in the same table is shown at 76.08 euros with a marginal daily decline of 0.39 percent, suggesting that the incoming constituent currently enjoys a slightly stronger price momentum than the outgoing diagnostics group.

Diagnostics portfolio as growth driver

DiaSorin is known for its specialized in vitro diagnostics portfolio, including immunodiagnostic and molecular assays used by hospital and laboratory customers for infectious disease testing, oncology markers and other clinical applications, positioning the company in a structurally growing segment of the global healthcare market.

Stock trading around the mid 70 euro range

Based on the same Borsa Italiana data for September 3, 2026, DiaSorin stock is trading near the mid 70 euro range with intraday quotes clustered around 76 euros, placing the current price level somewhat below the recent intraday peak mentioned by Italian financial media, which referred to a fast move up to approximately 77.50 euros before the stock eased back.

DiaSorin stock key data

• Company: DiaSorin S.p.A.
• ISIN: IT0003497168
• Ticker: DIA
• Trading venue: Borsa Italiana, FTSE MIB constituent until the upcoming index change
• Price (as of September 3, 2026): 76.22 EUR
• Market capitalization: not specified in the available price snapshot
• Sector / Industry: Healthcare, Diagnostics
• Index membership: FTSE MIB (Italy) until the announced replacement effective September 21, 2026